The Company has obtained from the SFDA of China a Good Manufacturing Practices (GMP) Certificate related to the plant facility and quality assurance system for production of the "Small Volume Parenteral Solutions". As a result, the Company is starting shipment of its new product Slounase® to its distributors over China today.